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Introduction:  Chronic  urticaria  (CU)  is characterized  by  repeated  occurrence  of  wheals  or  itching  for
more than  6 weeks.  When  urticarial  symptoms  repeatedly  occur despite  taking  western  medicines  such
as antihistamines,  herbal  medicines  have  potential  as  an  alternative  for them.  Among  various  herbal
medications  for  CU,  we  mostly  prescribe  Gwakhyangjeonggi-san (GJS)  made  by  Lee  Je-ma,  the founder  of
Sasang  Constitutional  Medicine  (SCM)  in  Korea.  The  purpose  of this  study  is  to investigate  whether  GJS
actually  helps  in  treating  CU.
Methods:  We  performed  a retrospective  review  of  the  medical  records  of 30 patients  to  whom  GJS  was
administered  in  order  to compare  the  changes  in  urticaria  activity  scores  (UAS)  and  in  western  medicines
taken  at  the  beginning  of treatment  of GJS and  at 6  months  after completion  of the  treatment.
Results:  The  UAS  after  6  months  from  treatment  (1.63  ±  2.06)  with  GJS  for an  average  of  57.30 ± 35.88 days
was  signiﬁcantly  decreased  compared  to the  score  before  treatment  (5.10 ± 0.99),  showing  a statistically
signiﬁcant  difference  (p <  0.001).  46.67%  of the  patients  (14/30  patients)  reported  that  their  symptoms
were  completely  eliminated,  and  66.67%  of  the  patients  taking  anti-histamines  (18/27  patients)  were
able to  stop  it completely.
Discussion:  Based  on the  ﬁndings,  GJS  helps  patients  reduce  taking  western  medicines  such  as  anti-
histamines,  and  we  hypothesize  that  GJS improves  symptoms  of  CU  by the  gastrointestinal  protective
activity  and  anti-oxidative/depressive  effect.  Further  clinical  study  is warranted.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Chronic urticaria (CU)1 is characterized by repeated occur-
ence of wheals or itching for more than 6 weeks, and etiological
auses are not clear. The treatment of CU involves alleviation
f symptoms by prescribing antihistamines until the disease is
ealed naturally.2,3 Various medicines such as corticosteroids or
yclosporine may  be required with poor response to antihis-
amines, but potential adverse effects of them limit therapeutic
egimens.4–6 Patients suffering recurring symptoms despite the
epeated administration of western medicines are likely to seek
reatment methods to substitute for them. In East Asian regions, by
irtue of safety and fewer side effects, a variety of herbal medicines
uch as Xiao-Feng San are used in the treatment of CU,7–9 and they
re likely to be a good substitute for western medicines. We  are
lso prescribing a variety of herbal medicines to CU patients in our
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outpatient clinic, and among them, the most-prescribing decoction
is Gwakhyangjeonggi-san (GJS)10 made by Lee Je-ma, the founder
of Sasang Constitutional Medicine (SCM) in Korea. However, we
can hardly ﬁnd clinical reports about GJS for CU. In this study, we
investigate that GJS actually helps in treating CU.
2. Methods
We  consecutively chose and retrospectively reviewed medical
records of 30CU patients (Table 1) who visited Dongguk Univer-
sity Bundang Hospital from December 2012 to June 2013, and
were treated with GJS for at least one month. Prior consents were
obtained.
GJS was  prepared as follows. The amount twice the dose of herbs
(Table 2) was  boiled in 700 ml  distilled water for 2 h to concen-
trate it to 240 ml.  Then, GJS was administered to patients twice a
day, 30 min  after meals in the morning and evening. For children
under the age of 10, 1/3 of the amount for adults was administered.
The treatment periods of each patient depended on the intensity of
symptoms.
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Table 1
Patients’ characteristic, and changes in both symptoms of urticaria and western medicines taken before and 6 months after treatment with Gwakhyangjeonggi-san (GJS).
Sex/Age BMI  (kg/m2) Disease duration
(Months)
Treatment
duration (Days)
Wheals or hives (A) Itch (B) Urticaria activity score
(A + B)
Anti-histamines (with
steroids or sedatives)
Prea F/Ub Pre F/U Pre F/U Pre F/U
1 F/42 19.25 2 49 1 1 3 1 4 2 ©c d
2 F/31 20.87 2 20 2 1 1 1 3 2 © 
3  F/31 20.94 2 56 3 0 3 0 6 0 © (Steroids)
4  F/33 19.96 3 22 3 1 3 0 6 1 © 
5  F/20 17.08 3 30 3 0 3 0 6 0 ©
6  M/13 18.36 3 79 2 2 3 3 5 5
7  F/27 27.03 3 57 3 0 3 0 6 0 ©
8  F/30 20.25 3 62 3 0 3 0 6 0 ©
9  F/24 22.24 3 27 3 0 3 0 6 0 ©
10  F/21 19.74 4 32 2 1 1 1 3 2
11  F/29 19.74 4 120 3 0 3 0 6 0 © (Steroids)
12  F/31 21.98 4 49 2 1 1 0 3 1 ©
13  F/30 17.09 4 35 3 0 3 2 6 2 ©
14  M/9  16.07 4 44 2 0 3 0 5 0 © (Sedatives)
15  F/39 19.81 6 148 3 3 3 3 6 6 © ©
16  F/27 21.03 7 25 3 0 3 0 6 0 ©
17  F/6 17.25 11 46 2 0 3 0 4 0 ©(Sedatives)
18  F/46 23.17 11 39 2 2 3 3 5 5
19  M/23 24.08 14 100 1 0 3 0 4 0 ©
20  F/29 19.68 16 51 2 0 3 1 5 1 ©
21  F/54 19.43 16 71 2 0 3 0 5 0 ©
22  F/31 18.25 17 43 1 0 3 0 4 0 ©
23  F/26 18.25 19 141 2 1 3 1 5 2 ©
24  M/23 20.6 22 35 3 0 3 0 6 0 ©
25  F/17 18.19 32 86 2 1 3 1 5 2 © ©
26  F/30 19.93 36 44 3 0 3 0 6 0 ©
27  F/40 19.93 40 29 2 1 3 1 5 2 © (Steroids) ©
28  M/9  16.41 48 19 3 3 3 3 6 6 © ©
29  F/23 19.12 60 39 2 2 3 3 5 5 © ©
30  F/50 21.19 97 121 2 2 3 3 5 5 © ©
Total  30 persons 14e 27f 9g (18h)
Male:female 5:25 19.90 16.53 57.30 2.33 0.73 2.80 0.90 5.10 1.63 46.67% (14e/30)
Age  28.13 ± 11.42 ±2.32 ±21.45 ±35.88 ±0.66 ±0.94 ±0.61 ±1.18 ±0.99 ±2.06 66.67% (18h/27f)
(Mean  ± Standard-deviation)
a Pre, Pre-treatment.
b F/U, Follow-up after 6 months from the last treatment.
c ©,  Regularly taking anti-histamines.
d , Taking anti-histamines whenever necessary
e 14, Fourteen persons whose symptoms disappeared 6 months after the last treatment.
f 27, Twenty-seven persons who  already took western medicines before treatment.
g 9, Nine persons who still took western medicines 6 months after the last treatment.
h 18, Eighteen persons who  stopped western medicines 6 months after the last treatment.
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Table 2
Compositions and dose of one-time of Gwakhyangjeonggi-san (GJS) in Sasang Constitutional Medicine (SCM) and Huoxiang-zhengqi-san (HZS) in Traditional Chinese Medicine
(TCM).
Medicinal plants Scientiﬁc name Weight (g)
GJS in SCMa HZS in TCMb
Agastachis Herba Agastache rugosa Fischer et Meyer O. Kuntze 6 6
Perillae Folium Perilla frutescens var. acuta Kudo 4 4
Pinelliae Tuber Pinellia ternata Breitenbach 2 2
Arecae Pericarpium Areca Catechu Linne 2 2
Glycyrrhizae RadixPreparta cum Mel  Glycyrrhiza uralensis Fischer, Glycyrrhiza glabra Linne 2 2
Citri  Unshius Pericarpium Citrus unshiu Markovich 2 2
Citri  Unshius PericarpiumImmaturus Citrus unshiu Markovich 2
Atractylodis Rhizoma Atractylodes chinensis Koidzumi 2
Atractylodis Rhizoma Alba Atractylodes macrocephala Koidzumi 2 2
Cinnamomi Cortex Cinnamomum cassia Blume 2
Zizyphi Fructus Zizyphus jujuba Miller var. inermis Rehder 2
Alpiniae Oxyphyllae Fructus Alpinia oxyphylla Miquel 2
Zingiberis Rhizoma Zingiber ofﬁcinale Roscoe 2
Zingiberis Rhizoma Recens Zingiber ofﬁcinale Roscoe 2
Angelicae Dahuricae Radix Angelica dahurica Bentham et Hooker 2
Poria  Sclerotium Poria cocos Wolf 2
Magnoliae Cortex Magnolia ofﬁcinalis Rehder et Wilson 2
Platycodonis Radix Playtcodon grandiﬂorum A. De Candolle 2
Total  amounts 34 28
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Fig. 1. Urticaria activity scores (UAS) before and 6 months after Gwakhyangjeonggi-
san (GJS) treatment in Sasang Constitutional Medicine for chronic urticaria (CU).
UAS, which ranges from 0 (none) to 6 (Severe), includes scores for both wheal ora GJS in SCM: Gwakhyangjeonggi-san in Sasang Constitutional Medicine.
b HZS in TCM: Huoxiang-zhengqi-san in Traditional Chinese Medicine.
We  compared the urticaria activity score (UAS; Total scores
 ∼ 6)11,12 which patients rated by themselves before treatment
nd after 6 months from the last treatment. CU has a high prob-
bility of recurrence, and in order to verify the effect of GJS on CU,
e measured UAS after 6 months from the last treatment instead of
he treatment completion. Also, types of western medicines were
ompared before and after 6 months with GJS.
All data were analyzed using Window SPSS 20.0, and the changes
f UAS were analyzed by Wilcoxon signed rank test. P-values less
han 0.05 were considered statistically signiﬁcant. All data were
xpressed in mean ± SD.
. Results
Thirty patients (Male:Female 5:25; Mean age 28.13 ± 11.42
ears; mean body mass index 19.90 ± 2.32 kg/m2) had been suffer-
ng CU for an average of 16.53 ± 21.45 months, and were treated
ith GJS for 57.30 ± 35.88 days. The average scores for wheals,
tching, and UAS before treatment were 2.33 ± 0.66, 2.80 ± 0.61,
nd 5.10 ± 0.99, respectively, but they were reduced to 0.73 ± 0.94,
.90 ± 1.18, and 1.63 ± 2.06 after 6 months. These changes were also
tatistically signiﬁcant (p < 0.001) (Table 1, and Fig. 1). In particular,
he symptoms of 14 out of 30 patients (46.67%) were completely
liminated (UAS = 0). On the other hand, 27 out of 30 patients had
een taking anti-histamines even before treatment with GJS, but
fter 6 months from the last treatment with GJS, 18(66.67%; 18/27)
atients were able to stop the administration of anti-histamines.
our out of 5 patients (Patient number; P# 3, 11, 14, and 17 in
able 1) who had been taking steroids or sedatives along with anti-
istamines due to severe symptoms were able to stop taking them
fter treatment with GJS. Three patients (P# 1, 2, and 4) who  had
een taking anti-histamines regularly were able to reduce the num-
er of times of taking the drugs. However, 6 patients (P# 6, 15, 18,
8, 29, and 30) showed no signiﬁcant changes of UAS before and
fter treatment with GJS.
. DiscussionGJS in SCM is derived from Huoxiang-zhengqi-san in Traditional
hinese Medicine (Table 2).13 Lee Je-ma in his book, Dong-Yi-Soo-
e-Bo-Won (The Principle of Life Preservation in Oriental medicine)14hives and itch, of which each topic is up to 3 points. Six months after treatment with
GJS  for CU, UAS (1.63 ± 2.06) was much lower than before treatment (5.10 ± 0.99).
The result was  statistically signiﬁcant (Wilcoxon signed rank test: * p < 0.001).
often used GJS for people who do not have good appetite and often
suffer gastrointestinal disorders such as irritable bowel syndrome
physically,15,16 or tend to be nervous psychologically.17
Recent experimental studies in Korea have reported that GJS
is effective on anti-allergic effect.10,13 Agastachis Herba,  the main
ingredient of GJS has been used for treatment of anorexia, vomit-
ing, and diarrhea, however, some experimental studies examined
that Agastachis Herba had an anti-fungal18 and anti-oxidative19
effect. Cinnamomi Cortex has both anti-oxidative effects20 and
gastroprotective activities21 during regular ingestion. Other com-
ponents of GJS such as Citri Unshius Pericarpium22 and Alpiniae
Oxyphyllae Fructus23 also have anti-oxidative effect due to vari-
ous mechanisms. Type I hypersensitivity reactions are commonly
implicated in cutaneous adverse food reactions.24 Gluten which
causes gastrointestinal symptoms such as celiac disease, and
pseudo-allergens such as aromatic compounds or artiﬁcial preser-
vatives may  be associated with the occurrence of CU.25 Oxidative
stress conditions were observed in the skin lesions of patients with
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29. Ito N, Yabe T, Gamo Y, Nagai T, et al. Rosmarinic acid from Perillae Herba
produces an antidepressant-like effect in mice through cell proliferation in
the hippocampus. Biol Pharm Bull. 2008;31:1376–1380.J.-H. Kim, S.-S. Park / Complementary
diopathic CU.26–28 Therefore, it seems that Agastachis Herba and
innamomi Cortex can help preventing repeated adverse food reac-
ions from deteriorating into CU, and herbs with anti-oxidative
ffects in GJS work synergistically to contribute to decreasing the
ymptoms of CU.
Perillae Folium,  the second main ingredient in GJS has an anti-
epressive effect.29 CU patients often suffer lack of sleep due to
hronic itching or have difﬁculty in personal relationships and
ocial activities due to external urticarial lesion or angioedema.30
herefore, it is inferred that Perillae Folium helps reduce the mental
tress instead of sedatives, which occurs as quality of life deterio-
ates due to CU.
As a result, GJS has potential as an alternative for long-term users
f western medicines who suffer refractory CU with lack of sleep,
ental irritability, and physical discomfort such as gastrointestinal
isorders.
Our case series, by the nature of retrospective study, have no
ontrol allowing various biases and errors. GJS has not yet received
Good Manufacturing Practice’. Despite these limitations, further
tudies on GJS will make a contribution to investigate its efﬁcacy.
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